Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ·Healthcare·Biotechnology
$4.79
—
Mkt Cap $1.65M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$8.50
Range $6.00 – $11.00
Implied Upside
+77.6%
Consensus $8.50 vs current $4.79
NASDAQ·Healthcare·Biotechnology
$4.79
—
Mkt Cap $1.65M
No recent rating data.
Price Target (3 analysts)
$8.50
Range $6.00 – $11.00
+77.6%
Consensus $8.50 vs current $4.79